Biomarker | Study group (median (IQR)) | |||||
Males | Females | |||||
Controls | Concussion group | P value | Controls | Concussion group | P value | |
Tau | 0.9±1.5 | 0.9±1.4 | 0.83366 | 1.1±1.0 | 0.7±1.0 | 0.42372 |
GFAP | 103.1±61.6 | 97.0±73.8 | 0.97606 | 134.0±124.4 | 99.9±71.2 | 0.65272 |
NfL | 17.0±7.7 | 15.5±11.0 | 0.42952 | 14.3±10.8 | 14.6±9.6 | 0.61006 |
Aβ40 | 63.5±56.7 | 45.3±76.8 | 0.65994 | 40.4±55.4 | 35.9±58.1 | 0.95216 |
Aβ42 | 4.4±4.0 | 3.0±4.5 | 0.37346 | 2.8±3.6 | 2.6±3.8 | 0.93624 |
The Mann-Whitney U test was used to calculate significance. No significant findings were found in the male or female group.
GFAP, glial fibrillar acidic protein.